The BraTS 2015 dataset is a dataset for brain tumor image segmentation. It consists of 220 high grade gliomas (HGG) and 54 low grade gliomas (LGG) MRIs. The four MRI modalities are T1, T1c, T2, and T2FLAIR. Segmented “ground truth” is provide about four intra-tumoral classes, viz. edema, enhancing tumor, non-enhancing tumor, and necrosis.
66 PAPERS • 1 BENCHMARK
LiTS17 is a liver tumor segmentation benchmark. The data and segmentations are provided by various clinical sites around the world. The training data set contains 130 CT scans and the test data set 70 CT scans. Image Source: https://arxiv.org/pdf/1707.07734.pdf
38 PAPERS • 3 BENCHMARKS
Introduced by Da et al. in DigestPath: a Benchmark Dataset with Challenge Review for the Pathological Detection and Segmentation of Digestive-System
22 PAPERS • 1 BENCHMARK
BRATS 2016 is a brain tumor segmentation dataset. It shares the same training set as BRATS 2015, which consists of 220 HHG and 54 LGG. Its testing dataset consists of 191 cases with unknown grades. Image Source: https://sites.google.com/site/braintumorsegmentation/home/brats_2016
13 PAPERS • NO BENCHMARKS YET
BRATS 2014 is a brain tumor segmentation dataset.
5 PAPERS • 1 BENCHMARK
CSAW-S is a dataset of mammography images which includes expert annotations of tumors and non-expert annotations of breast anatomy and artifacts in the image.
4 PAPERS • NO BENCHMARKS YET
https://drive.google.com/file/d/1X_JTfD8Ch-IxmG5VHtKk_xGZT336Fl1Q/view?usp=drive_link
1 PAPER • NO BENCHMARKS YET
Unique radiogenomic dataset from a Non-Small Cell Lung Cancer (NSCLC) cohort of 211 subjects. The dataset comprises Computed Tomography (CT), Positron Emission Tomography (PET)/CT images, semantic annotations of the tumors as observed on the medical images using a controlled vocabulary, segmentation maps of tumors in the CT scans, and quantitative values obtained from the PET/CT scans. Imaging data are also paired with gene mutation, RNA sequencing data from samples of surgically excised tumor tissue, and clinical data, including survival outcomes.
Highlights
0 PAPER • NO BENCHMARKS YET